U.S. Physical Therapy, Inc. (NYSE:USPH) has been assigned an average rating of “Buy” from the seven brokerages that are currently covering the company, Marketbeat.com reports. Four research analysts have rated the stock with a hold recommendation, one has given a buy recommendation and one has given a strong buy recommendation to the company. The average 12 month price objective among analysts that have updated their coverage on the stock in the last year is $113.67.

A number of brokerages have recently weighed in on USPH. TheStreet lowered shares of U.S. Physical Therapy from a “b” rating to a “c+” rating in a report on Friday, November 2nd. Cantor Fitzgerald raised their price objective on shares of U.S. Physical Therapy from $103.00 to $107.00 and gave the company a “neutral” rating in a report on Friday, November 2nd.

U.S. Physical Therapy stock opened at $109.19 on Thursday. The company has a market cap of $1.51 billion, a price-to-earnings ratio of 52.50, a price-to-earnings-growth ratio of 4.10 and a beta of 1.21. U.S. Physical Therapy has a 52-week low of $70.05 and a 52-week high of $129.65. The company has a current ratio of 1.93, a quick ratio of 1.93 and a debt-to-equity ratio of 0.26.

U.S. Physical Therapy (NYSE:USPH) last released its earnings results on Thursday, November 1st. The company reported $0.64 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.58 by $0.06. The company had revenue of $113.10 million for the quarter, compared to analyst estimates of $112.79 million. U.S. Physical Therapy had a net margin of 5.58% and a return on equity of 17.64%. The firm’s revenue for the quarter was up 9.8% on a year-over-year basis. Equities analysts expect that U.S. Physical Therapy will post 2.56 earnings per share for the current fiscal year.

The company also recently disclosed a quarterly dividend, which will be paid on Friday, December 7th. Stockholders of record on Friday, November 9th will be issued a $0.23 dividend. The ex-dividend date of this dividend is Thursday, November 8th. This represents a $0.92 dividend on an annualized basis and a dividend yield of 0.84%. U.S. Physical Therapy’s payout ratio is 44.23%.

In related news, CFO Lawrance W. Mcafee sold 3,100 shares of the stock in a transaction on Friday, November 2nd. The shares were sold at an average price of $113.29, for a total value of $351,199.00. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, Director Mark J. Brookner sold 500 shares of the stock in a transaction on Friday, November 16th. The shares were sold at an average price of $118.50, for a total transaction of $59,250.00. The disclosure for this sale can be found here. Insiders sold a total of 8,725 shares of company stock worth $1,008,262 over the last 90 days. Company insiders own 2.50% of the company’s stock.

Hedge funds and other institutional investors have recently bought and sold shares of the stock. Wells Fargo & Company MN grew its position in shares of U.S. Physical Therapy by 6.5% in the 2nd quarter. Wells Fargo & Company MN now owns 102,173 shares of the company’s stock valued at $9,810,000 after buying an additional 6,244 shares during the last quarter. Northern Trust Corp grew its position in shares of U.S. Physical Therapy by 10.3% in the 2nd quarter. Northern Trust Corp now owns 217,737 shares of the company’s stock valued at $20,903,000 after buying an additional 20,295 shares during the last quarter. Envestnet Asset Management Inc. grew its position in shares of U.S. Physical Therapy by 38.2% in the 2nd quarter. Envestnet Asset Management Inc. now owns 5,268 shares of the company’s stock valued at $505,000 after buying an additional 1,456 shares during the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS purchased a new position in shares of U.S. Physical Therapy in the 2nd quarter valued at $257,000. Finally, Oppenheimer Asset Management Inc. grew its position in shares of U.S. Physical Therapy by 50.3% in the 2nd quarter. Oppenheimer Asset Management Inc. now owns 5,316 shares of the company’s stock valued at $510,000 after buying an additional 1,780 shares during the last quarter. 99.58% of the stock is currently owned by hedge funds and other institutional investors.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.

Featured Article: Systematic Risk

Receive News & Ratings for U.S. Physical Therapy Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for U.S. Physical Therapy and related companies with MarketBeat.com's FREE daily email newsletter.